Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Risk
Injury
Failure
Loss
ESKD
GFR Criteria
Increased SCreat x
1.5 or GFR decrease
>25%
Increased SCreat x
or GFR decrease
>50%
Increased SCreat x 3
or GFR decrease
75% or SCrea
>4mg/dl
Urine
Output
Criteria
UO
<5ml/kg/h x
6hr
UO
<5ml/kg/h x
12hr
UO
<3ml/kg/h x
24hrs oliguria
Anuria x
12hrs
Urine
Sepsis
Intestinal obstruction
Hepatorenal syndrome due to antigen antibody
reactions
Toxic drugs:
Aminoglycosides (gentamicin, amikacin,
neomycin)
Wasp stings
Bee stings
Toxins:
Plant toxins
*weight losing drugs such as Bangkok pills
contain aristolochic acid Renal failure, renal
insufficiency
Snake bites
Rhabdomyolysis
Blackwater fever in falciform malariae
Radiocontrast agents
Renal
(Intrinsic to kidney)
Glomerulonephritis
Post infectious (post streptococcal, post viral)
SystemicLupus Erythematosus
Henoch-Schonlein Purpura (HSP)
Membranoproliferative glomerulonehritis (MPGN)
ANCA GN
Anti-neutrophil cytoplasmic autoantibodes (ANCA)
assoc. w/ necrotizing & crescentic GN
Anti-Glomerular Basement Membrane disease
Vascular: renal artery stenosis affecting blood
supply to kidneys
Hemolytic-uremic syndrome (HUS)
Renal vein thrombosis
Renal artery thrombosis
Acute tubulointerstitial nephritis allergy to drugs
causing sloughing off of tubular membrane
Infectious
Epstein-Barr virus (EBV)
Leptospirosis (hepatorenal syndrome)
Drugs including herbal preparations
Acute pyelonephritis
Tumor infiltration
B. MANAGING AKI
Treatment or removal of the cause to address
treatment
Maintenance of physiological homeostasis while
recovery takes place
1) Nutritional support (30-35 kcal/kg/day) as
mixture of CHO and lipids, & CHON at 12g/kg (most patients have poor appetite so
IV solutions may be given)
2) Hyperkalemia must be promptly treated
(Use hyper-K regimen: nebulize the patient
Kayexylate may be given, calcium gluconateemergency management)
a) Insulin and dextrose (D5050)
*Insulin shifts K into cell
b) Sodium bicarbonate given if metabolic
acidosis is present (orally/intravenously)
c) Calcium gluconate
*Replaces Ca and help entry of K back into
the cell
d) RRT (Renal replacement therapy w/ 2
modalities: Peritoneal & Hemodialysis)
3) Metabolic acidosis (due to failure to
conserve HCO3)
4) Anemia (due to disruption of EPO production
in renal interstitial cell)
5) Renal doses of drugs
6) Stress ulcer prophylaxis
*Preserve the viability of GI mucosa so that
you can give H2 receptor antagonists &
potent pump inhibitors (PPI)
7) Prevent infection and iatrogenic causes of
infection
Causes
1.
Metabolic disorders
Diabetes mellitus most common cause
2.
3.
4.
5.
6.
7.
Stage
Creatinine
clearance
Conditions
/associated
90 or more
ml/min/1.73 m2
with risks of
developing CKD
(lupus, nephrotic
syndrome)
II
60-89 ml/min/1.73
m2 (mild)
30-59 ml/min/1.73
m2 (moderate)
15-29 ml/min/1.73
m2 (severe) S/S of
III
IV
S/s present:
encephalopathy,
uremia, HTN,
hypercalemia,
<15 ml/min/1.73 m2
(end stage)
Dialysis is indicated usually in stages IV and V
End Stage Renal Disease
Progressive deterioration of renal function and
further loss of nephrons to a point at w/c the
emodialysis
Dialyzer serves as glomerulus